13-34942867-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBS1_SupportingBS2
The NM_001385012.1(NBEA):c.47C>T(p.Pro16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000709 in 1,409,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P16P) has been classified as Likely benign.
Frequency
Consequence
NM_001385012.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NBEA | NM_001385012.1 | c.47C>T | p.Pro16Leu | missense_variant | 1/59 | ENST00000379939.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NBEA | ENST00000379939.7 | c.47C>T | p.Pro16Leu | missense_variant | 1/59 | 5 | NM_001385012.1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150552Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000378 AC: 2AN: 52968Hom.: 0 AF XY: 0.0000356 AC XY: 1AN XY: 28072
GnomAD4 exome AF: 0.00000556 AC: 7AN: 1259062Hom.: 0 Cov.: 24 AF XY: 0.00000651 AC XY: 4AN XY: 614562
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150552Hom.: 0 Cov.: 31 AF XY: 0.0000272 AC XY: 2AN XY: 73498
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.47C>T (p.P16L) alteration is located in exon 1 (coding exon 1) of the NBEA gene. This alteration results from a C to T substitution at nucleotide position 47, causing the proline (P) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at